129 related articles for article (PubMed ID: 1510397)
1. Intracellular activity of zidovudine (3'-azido-3'-deoxythymidine, AZT) against Salmonella typhimurium in the macrophage cell line J774-2.
Herrmann JL; Lagrange PH
Antimicrob Agents Chemother; 1992 May; 36(5):1081-5. PubMed ID: 1510397
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial properties of azidothymidine (AZT).
Monno R; Marcuccio L; Valenza MA; Leone E; Bitetto C; Larocca A; Maggi P; Quarto M
Acta Microbiol Immunol Hung; 1997; 44(2):165-71. PubMed ID: 9330665
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U).
Elwell LP; Ferone R; Freeman GA; Fyfe JA; Hill JA; Ray PH; Richards CA; Singer SC; Knick VB; Rideout JL
Antimicrob Agents Chemother; 1987 Feb; 31(2):274-80. PubMed ID: 3551832
[TBL] [Abstract][Full Text] [Related]
4. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
Bhalla K; Birkhofer M; Grant S; Graham G
Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
Richman DD
Am J Med; 1990 May; 88(5B):8S-10S. PubMed ID: 2186629
[TBL] [Abstract][Full Text] [Related]
6. Conditions required for the antibacterial activity of zidovudine.
Lewin CS; Amyes SG
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):737-41. PubMed ID: 2506045
[TBL] [Abstract][Full Text] [Related]
7. [Fundamental and clinical studies on aztreonam in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M
Jpn J Antibiot; 1985 Nov; 38(11):3273-84. PubMed ID: 4094059
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of 3'-azido-3'-deoxythymidine (AZT) on normal human polymorphonuclear cell and monocyte-macrophage functional capacities.
De Simone C; Maffione AB; Calvello R; Nacci C; Sciannameo G; Greco B; Caradonna L; Pece S; Antonaci S; Jirillo E
Immunopharmacol Immunotoxicol; 1996 May; 18(2):161-78. PubMed ID: 8771365
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of zidovudine alone and in combination with ciprofloxacin against Salmonella and Escherichia coli.
Mascellino MT; Iona E; Iegri F; De Gregoris P; Farinelli S
FEMS Immunol Med Microbiol; 1993 Jun; 7(1):23-8. PubMed ID: 8364519
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.
Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC
Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure.
Turk G; Moroni G; Pampuro S; Briñón MC; Salomón H
Int J Antimicrob Agents; 2002 Oct; 20(4):282-8. PubMed ID: 12385685
[TBL] [Abstract][Full Text] [Related]
12. The influence of the SOS response on the activity of 4-quinolones and zidovudine against some strains of Enterobacteria.
Mascellino MT; Farinelli S; Iegri F; Iona E
New Microbiol; 1998 Jan; 21(1):31-40. PubMed ID: 9497927
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
Menashe O; Kaganskaya E; Baasov T; Yaron S
Antimicrob Agents Chemother; 2008 Mar; 52(3):920-6. PubMed ID: 18172002
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
Kumar R; Wang L; Wiebe LI; Knaus EE
J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
[TBL] [Abstract][Full Text] [Related]
15. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
Chang S; Griesgraber GW; Southern PJ; Wagner CR
J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine induces the expression of cellular resistance affecting its antiviral activity.
Dianzani F; Antonelli G; Turriziani O; Riva E; Simeoni E; Signoretti C; Strosselli S; Cianfriglia M
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1471-8. PubMed ID: 7888202
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antibacterial activity of novel 5'-O-analog derivatives of zidovudine as potential prodrugs.
Moroni GN; Bogdanov PM; Briñón MC
Nucleosides Nucleotides Nucleic Acids; 2002; 21(3):231-41. PubMed ID: 11991164
[TBL] [Abstract][Full Text] [Related]
18. Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages.
Yang CY; Hsu CY; Fang CS; Shiau CW; Chen CS; Chiu HC
J Microbiol Immunol Infect; 2019 Aug; 52(4):638-647. PubMed ID: 31239204
[TBL] [Abstract][Full Text] [Related]
19. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
[TBL] [Abstract][Full Text] [Related]
20. 5'-aminocarbonyl phosphonates as new zidovudine depot forms: antiviral properties, intracellular transformations, and pharmacokinetic parameters.
Khandazhinskaya AL; Yanvarev DV; Jasko MV; Shipitsin AV; Khalizev VA; Shram SI; Skoblov YS; Shirokova EA; Kukhanova MK
Drug Metab Dispos; 2009 Mar; 37(3):494-501. PubMed ID: 19106116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]